Early identification of progressive multifocal leukoencephalopathy in patients on natalizumab

27th July 2015

A method for early detection of Natalizumab-associated progressive multifocal leukoencephalopathy in the absence of clinical symptoms

Predictive factors for developing MS

22nd July 2015

Identifying risk factors for developing further attacks and disability accumulation in patients with “clinically isolated syndrome"

Breaking down the barriers

14th July 2015

One girl’s story of fighting for success in Mumbai, India

Take the Pledge

11th July 2015

The MS Society of Canada asks Canadians to pledge, donate and share

$28 million USD investment for new research

9th July 2015

The National MS Society invests $28 million USD in new MS research projects

New educational comic for children

7th July 2015

MS Australia has endorsed an educational comic to make MS information more accessible for children

Characteristics of primary progressive MS

4th July 2015

Researchers in Canada have investigated the natural history of 500 people with primary progressive MS

Hematopoietic stem cells and MS

2nd July 2015

The results of a multi-centre, phase II, randomized trial

MSIF staff celebrate World MS Day

1st July 2015

Find out how staff from the MSIF office in London celebrated World MS Day

New treatment for spasticity and pain

30th June 2015

Radial shock wave therapy has been used to treat spasticity and pain in Italy

Spinal cord is affected early in primary progressive MS

25th June 2015

Study suggests that early spinal neurodegeneration may underlie clinical impairment

Smoking worsens MS

16th June 2015

Evidence shows that smoking increases the risk of developing MS and accelerates disease progression